Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 304,964 | 260,630 | 217,003 | 178,357 | 193,513 |
| Marketable Securities | 107,532 | N/A | N/A | N/A | N/A |
| Receivables | 86,366 | 91,058 | 93,980 | 76,010 | 84,075 |
| Inventories | 33,725 | 34,236 | 36,664 | 37,437 | 40,737 |
| Other current assets | 656 | 2,047 | 2,146 | 2,987 | 4,264 |
| TOTAL | $554,306 | $400,621 | $358,277 | $311,342 | $344,219 |
| Non-Current Assets | |||||
| PPE Net | 514 | 544 | 427 | 324 | 483 |
| Investments And Advances | 393,957 | 507,718 | 536,435 | 628,437 | 560,978 |
| Intangibles | 226,338 | 228,849 | 235,360 | 241,800 | 248,240 |
| Other Non-Current Assets | 125,945 | 93,880 | 94,418 | 85,709 | 89,587 |
| TOTAL | $746,754 | $830,991 | $866,640 | $956,270 | $899,288 |
| Total Assets | $1,301,060 | $1,231,612 | $1,224,917 | $1,267,612 | $1,243,507 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 192,028 | 191,843 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,132 | 4,170 | 2,039 | 890 | 6,717 |
| Accrued Expenses | 10,798 | 6,798 | 8,179 | 4,255 | 10,442 |
| TOTAL | $236,083 | $223,750 | $28,206 | $29,879 | $38,134 |
| Non-Current Liabilities | |||||
| Long Term Debt | 256,316 | 255,972 | 447,282 | 446,759 | 446,234 |
| Deferred Revenues | 1,126 | 717 | 855 | 987 | 1,277 |
| Other Non-Current Liabilities | 117,502 | 83,348 | 83,914 | 83,486 | 83,621 |
| TOTAL | $373,818 | $339,320 | $531,196 | $534,052 | $530,418 |
| Total Liabilities | $609,901 | $563,070 | $559,402 | $563,931 | $568,552 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,676 | 62,601 | 62,563 | 62,445 | 63,227 |
| Common Shares | 627 | 626 | 626 | 628 | 633 |
| Retained earnings | -1,797 | -22,129 | -23,342 | 11,343 | -25,189 |
| Other shareholders' equity | 0 | 0 | 0 | 171 | 171 |
| TOTAL | $691,159 | $668,542 | $665,515 | $703,681 | $674,955 |
| Total Liabilities And Equity | $1,301,060 | $1,231,612 | $1,224,917 | $1,267,612 | $1,243,507 |